1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 593 F.Supp.3d
  5. 593 F.Supp.3d 96 (2022)
 

IN RE FOSAMAX PRODUCTS LIABILITY LITIGATION

MDL No. 2243. Civil Action No. 3:08-08 (FLW).

593 F.Supp.3d 96 (2022)

IN RE FOSAMAX (ALENDRONATE SODIUM) PRODUCTS LIABILITY LITIGATION. This Opinion Relates to: All Actions.

United States District Court, D. New Jersey.

Signed March 23, 2022.

OPINION

In this failure-to-warn case, more than 500 individuals ("Plaintiffs") who took Fosamax, a drug manufactured by Defendant Merck Sharp & Dohme ("Defendant" or "Merck") to prevent and treat osteoporosis in postmenopausal women, brought suit claiming that...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases